Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis | 6 | 2022 | 1229 | 1.800 |
Why?
|
Enterocolitis | 2 | 2024 | 106 | 1.620 |
Why?
|
Hepatitis | 3 | 2023 | 230 | 0.980 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 7 | 2016 | 380 | 0.980 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1190 | 0.910 |
Why?
|
Gastritis | 2 | 2022 | 198 | 0.880 |
Why?
|
Alanine Transaminase | 2 | 2024 | 606 | 0.830 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 365 | 0.760 |
Why?
|
Pancreatitis | 3 | 2024 | 1100 | 0.760 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 830 | 0.740 |
Why?
|
Methylprednisolone | 1 | 2021 | 384 | 0.700 |
Why?
|
DNA Glycosylases | 3 | 2020 | 124 | 0.660 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 72 | 0.660 |
Why?
|
Colitis, Lymphocytic | 1 | 2019 | 23 | 0.650 |
Why?
|
Gastroparesis | 1 | 2020 | 137 | 0.610 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2024 | 2421 | 0.580 |
Why?
|
Education, Medical, Continuing | 1 | 2022 | 830 | 0.580 |
Why?
|
Melanoma | 3 | 2020 | 5697 | 0.560 |
Why?
|
Immunotherapy | 5 | 2022 | 4642 | 0.540 |
Why?
|
Mucous Membrane | 1 | 2019 | 657 | 0.510 |
Why?
|
Neoplasms | 8 | 2024 | 22072 | 0.480 |
Why?
|
Adenomatous Polyposis Coli | 3 | 2015 | 218 | 0.480 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 311 | 0.390 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 180 | 0.390 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 796 | 0.350 |
Why?
|
Genetic Testing | 5 | 2020 | 3531 | 0.340 |
Why?
|
Diarrhea | 3 | 2022 | 1319 | 0.330 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10827 | 0.330 |
Why?
|
Gastroenterology | 1 | 2016 | 571 | 0.330 |
Why?
|
Paracentesis | 1 | 2009 | 98 | 0.320 |
Why?
|
Colorectal Neoplasms | 5 | 2020 | 6853 | 0.300 |
Why?
|
Dysentery | 1 | 2007 | 14 | 0.290 |
Why?
|
Adenoma | 2 | 2020 | 2148 | 0.280 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2803 | 0.270 |
Why?
|
Hospitalization | 2 | 2024 | 10790 | 0.270 |
Why?
|
Vitamin D | 1 | 2020 | 3291 | 0.270 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 615 | 0.260 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 345 | 0.260 |
Why?
|
Intestine, Small | 1 | 2012 | 1207 | 0.260 |
Why?
|
Retrospective Studies | 11 | 2024 | 80372 | 0.260 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5351 | 0.250 |
Why?
|
Early Detection of Cancer | 3 | 2016 | 3202 | 0.250 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2007 | 265 | 0.250 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 526 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2331 | 0.230 |
Why?
|
Medical Oncology | 1 | 2016 | 2313 | 0.230 |
Why?
|
Peutz-Jeghers Syndrome | 2 | 2016 | 59 | 0.220 |
Why?
|
Radioimmunotherapy | 1 | 2023 | 91 | 0.220 |
Why?
|
Middle Aged | 19 | 2024 | 220352 | 0.200 |
Why?
|
Liver | 1 | 2018 | 7509 | 0.200 |
Why?
|
Educational Measurement | 1 | 2009 | 1248 | 0.200 |
Why?
|
Internal Medicine | 1 | 2009 | 1048 | 0.200 |
Why?
|
Glucocorticoids | 2 | 2022 | 2145 | 0.200 |
Why?
|
Humans | 37 | 2024 | 760621 | 0.200 |
Why?
|
Lymphadenitis | 1 | 2022 | 98 | 0.190 |
Why?
|
Medical History Taking | 1 | 2004 | 773 | 0.180 |
Why?
|
Pancreatitis, Chronic | 2 | 2016 | 281 | 0.180 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2020 | 93 | 0.180 |
Why?
|
Liver Function Tests | 1 | 2021 | 524 | 0.170 |
Why?
|
Genes, APC | 1 | 2020 | 145 | 0.170 |
Why?
|
Immune System Diseases | 1 | 2022 | 258 | 0.170 |
Why?
|
Jews | 1 | 2020 | 364 | 0.160 |
Why?
|
Female | 21 | 2024 | 391270 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6315 | 0.150 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.150 |
Why?
|
Gastric Emptying | 1 | 2020 | 243 | 0.150 |
Why?
|
Aged | 12 | 2024 | 169152 | 0.150 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1841 | 0.140 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2363 | 0.140 |
Why?
|
Male | 18 | 2024 | 359744 | 0.140 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 1975 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2022 | 1063 | 0.130 |
Why?
|
Drug Resistance | 1 | 2021 | 1617 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 100 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2016 | 3529 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3986 | 0.120 |
Why?
|
Prognosis | 3 | 2024 | 29658 | 0.120 |
Why?
|
Feces | 1 | 2020 | 1455 | 0.110 |
Why?
|
Clinical Competence | 1 | 2009 | 4783 | 0.110 |
Why?
|
Genetic Counseling | 2 | 2009 | 624 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1869 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8515 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7269 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2611 | 0.100 |
Why?
|
Endosonography | 1 | 2016 | 607 | 0.100 |
Why?
|
Mutation | 2 | 2015 | 29932 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 24123 | 0.090 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 61 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1791 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2526 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1302 | 0.080 |
Why?
|
Internship and Residency | 1 | 2009 | 5870 | 0.080 |
Why?
|
Pedigree | 2 | 2009 | 4578 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 7408 | 0.080 |
Why?
|
Phenotype | 3 | 2020 | 16546 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2020 | 3061 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3767 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58995 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1369 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 429 | 0.070 |
Why?
|
Intestinal Fistula | 1 | 2007 | 143 | 0.070 |
Why?
|
Disease Progression | 1 | 2022 | 13502 | 0.060 |
Why?
|
Pyrroles | 1 | 2012 | 1137 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15687 | 0.060 |
Why?
|
Colonic Diseases | 1 | 2007 | 200 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2375 | 0.060 |
Why?
|
Colonoscopy | 2 | 2010 | 1387 | 0.060 |
Why?
|
Logistic Models | 3 | 2010 | 13314 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4107 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2852 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1829 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9631 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 25942 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9185 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4775 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15840 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5251 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2525 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4713 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4902 | 0.050 |
Why?
|
Mass Screening | 2 | 2010 | 5423 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13630 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9287 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6238 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2821 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2007 | 1548 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 935 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2007 | 1055 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3016 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11712 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 87810 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4283 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13262 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17790 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13308 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 58741 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 65017 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12965 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3615 | 0.030 |
Why?
|
Triage | 1 | 2020 | 987 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15289 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2004 | 3598 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7475 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20080 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12159 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6771 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9716 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2798 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7343 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5794 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 74359 | 0.020 |
Why?
|
Alleles | 1 | 2015 | 6898 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2688 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2608 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41335 | 0.010 |
Why?
|
United States | 1 | 2010 | 72461 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_